FindTrial
Sign In

Dexmedetomidine (a promising medication)when added to TAP block (a method to treat pain) can improve pain relief after laparoscopic hernia surgery

A Comparative, Randomized Double Blind Prospective Study to evaluate the use of Dexmedetomidine as adjuvant to Ropivacaine for Transversus Abdominis Plane (TAP) block in patients undergoing endoscopic Totally Extraperitoneal (TEP) repair of Hernia - TAP;TEP

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2012/12/003245
Enrollment
30
Registered
2012-12-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Age more than 18 years Either gender ASA I and II

Interventions

Intervention1: Dexmedetomidine: transversus Abdominis plane block with ropivacaine and Dexmedetomidine Intervention2: Ropivacaine with Dexmedetomidine: 20 ml of 0.375% via bilateral transversus abdom

Sponsors

Max Super Speciality Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA physical status I and II

Exclusion criteria

Exclusion criteria: Allergy to any Anesthetics Coronary artery disease Heart Block

Design outcomes

Primary

MeasureTime frame
Time to ambulate Discharge readinessTimepoint: sedation score, requirement for narcotic and any adverse events.—

Secondary

MeasureTime frame
sedation score, requirement for narcotic and any adverse events.Timepoint: Postoperative period—

Countries

India

Contacts

Public Contactaparna sinha

Institute of Minimal Access, Metabolic and Bariatric Surgery Max Super Speciality Hospital

apsin@hotmail.com09810035503

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026